Crossmark

Melatonin and mesenchymal stem cells co-administration alleviates chronic obstructive pulmonary disease via modulation of angiogenesis at the vascular-alveolar unit

Crossref DOI link: https://doi.org/10.1007/s00424-024-02968-3

Published Online: 2024-05-14

Published Print: 2024-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hanna, Mira https://orcid.org/0000-0002-5052-8335
Elnassag, Sabreen Sayed

Mohamed, Dina Hisham

Elbaset, Marawan Abd https://orcid.org/0000-0002-0861-6251
Shaker, Olfat

Khowailed, Effat A.

Gouda, Sarah Ali Abdelhameed
Funding

Funding for this research was provided by:

Cairo University
License Information

Text and Data Mining valid from 2024-05-14

Version of Record valid from 2024-05-14
More Information

Article History

Received: 29 November 2023

Revised: 31 March 2024

Accepted: 25 April 2024

First Online: 14 May 2024

Declarations

:

: The authors declare no competing interests.

: Experimental animal protocols and animal procedures complied with the highest International Criteria of Animal Experimentation and were approved by the Institutional Animal Care and Use Committee (IACUC), Cairo University (Approval number CU-III-F-50–21).

: The authors declare no competing interests.

Document is current

Any future updates will be listed below